ArticleTranslational oncology2018

Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models.

Sushil Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.